Literature DB >> 2785957

Immunological reactivity towards chondrocytes in rat and man: relevance to autoimmune arthritis.

E M Lance1.   

Abstract

Immunological investigation of articular chondrocytes obtained from rat and man have shown the presence of unique differentiation antigens on the cell surface demonstrated by poly- or monoclonal antibodies in both species, and by the analysis of T cell reactivity in the rat. Both species of chondrocytes express Class I antigens in common with all nucleated mammalian cells and, in man, individual specificities of the MHC A, B, and C locus can be identified using standard histocompatibility testing. Class II antigens are strongly expressed in the rat but are expressed poorly in the human specimens we have analyzed. This finding is at variance with the reports of others and may depend upon the antisera we have used or the diseased state of our patient donors. In the rat, T cell reactivity to chondrocyte antigens is strong and can be demonstrated in both proliferation and cytotoxic assay. Moreover, syngeneic reactivity is present in naive animals, suggesting that rats are not tolerant of their own CSDA. The cross-reactivity found on analysis of cytotoxic killing suggests a sharing of differentiation antigens amongst the different strains of rats and possibly a limited polymorphism for this system. In man, conventional assays for T cell reactivity are hampered by the presence of a soluble inhibitor of lymphocyte proliferation released by chondrocytes and as yet unidentified. The poor representation of Class II antigens on our chondrocyte specimens may further contribute to the difficulty in producing proliferation. On the other hand, early success is reported in finding a significant number of T cell clones isolated from the inflammatory membrane of patients with rheumatoid arthritis, which respond to chondrocyte antigens. The possibility that these antigens may play a role in the pathogenesis of inflammatory arthritis may be more readily explored by exploring these approaches.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785957     DOI: 10.1016/0165-2478(89)90013-8

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  8 in total

Review 1.  Functionality of decellularized matrix in cartilage regeneration: A comparison of tissue versus cell sources.

Authors:  Yu Sun; Lianqi Yan; Song Chen; Ming Pei
Journal:  Acta Biomater       Date:  2018-04-24       Impact factor: 8.947

2.  Monoclonal antibodies against human chondrocytes.

Authors:  J Bujia; M Sittinger; H Sudhoff; A Fisseler-Eckhoff; G R Burmester; E Kastenbauer; C Hammer
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-06       Impact factor: 2.416

3.  Chondrocyte-peripheral blood mononuclear cell interactions: the role of ICAM-1.

Authors:  A Horner; M E Davies; B Franz
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

Review 4.  Success rates and immunologic responses of autogenic, allogenic, and xenogenic treatments to repair articular cartilage defects.

Authors:  Christopher M Revell; Kyriacos A Athanasiou
Journal:  Tissue Eng Part B Rev       Date:  2009-03       Impact factor: 6.389

5.  Detection of cytokine activated chondrocytes in arthritic joints from pigs infected with Erysipelothrix rhusiopathiae.

Authors:  M E Davies; A Horner; B Franz; H J Schuberth
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

6.  Cartilage immunoprivilege depends on donor source and lesion location.

Authors:  B Arzi; G D DuRaine; C A Lee; D J Huey; D L Borjesson; B G Murphy; J C Y Hu; N Baumgarth; K A Athanasiou
Journal:  Acta Biomater       Date:  2015-05-28       Impact factor: 8.947

7.  In search of chondrocyte-specific antigen.

Authors:  Anna Osiecka-Iwan; Piotr Skopinski; Dorota M Radomska-Lesniewska; Anna Hyc
Journal:  Cent Eur J Immunol       Date:  2018-06-30       Impact factor: 2.085

Review 8.  Antigenic and immunogenic properties of chondrocytes. Implications for chondrocyte therapeutic transplantation and pathogenesis of inflammatory and degenerative joint diseases.

Authors:  Anna Osiecka-Iwan; Anna Hyc; Dorota M Radomska-Lesniewska; Adrian Rymarczyk; Piotr Skopinski
Journal:  Cent Eur J Immunol       Date:  2018-06-30       Impact factor: 2.085

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.